Antitumor activity and selectivity of a unique nanostructured polyoxoniobate
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
In vitro and in vivo experiments were carried out to evaluate the activity and antitumor selectivity of new niobium oligomers. A polyoxoniobate (PONb) and its chemical structure linked to the methylene blue dye (PONb-MB) showed promising results for some types of tumor cells. Molecular structures were determined for PONb and PONb-MB based on spectroscopic analyses with density functional theory calculations. Both caused a significant cell viability reduction in tumor cells (HeLa) with high effectiveness of 10.0% at 10 mg L-1, because of the reactivity oxygen species (ROS) generated on its chemical structure. Experimental quantitative analyzes demonstrated high selectivity for tumor cells (apoptosis 3x higher compared to MRC-5 healthy cells). Lower toxicities for healthy cells (e.g., MRC-5 and L929) confirm the selectivity of the synthesized compounds. It is noteworthy that PONb-MB and PONb-MB are physiologically soluble compounds and can be suitable for intravenous treatments. Ex vivo biodistribution studies in mice revealed a very low accumulation in organs such as the spleen, heart, liver, lungs, and kidneys. Additionally, almost no toxicity was observed in the mice post-injection, which was confirmed by biochemical analyzes.